Kymera Therapeutics's total assets for Q1 2026 were $1.67B, a decrease of -4.23% from the previous quarter. KYMR total liabilities were $129.38M for the fiscal quarter, a -20.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.